Skip to main content

CLOSED-LOOP VENTILATION AND OXYGENATION WITH DECISION SUPPORT FLUID RESUSCITATION TO TREAT MAJOR BURN INJURY WITH SMOKE-INDUCED ACUTE RESPIRATORY DISTRESS SYNDROME.

Shock (Augusta, Ga.)2025-01-22PubMed
Total: 72.0Innovation: 8Impact: 8Rigor: 6Citation: 8

Summary

In a conscious ovine model of burn plus smoke–induced ARDS, automated control of FiO2/PEEP and ventilation with decision-support fluid resuscitation improved static compliance, lowered driving pressure, and increased survival compared with manual settings. The closed-loop strategy yielded a higher net fluid balance without adverse interaction with automated PEEP control.

Key Findings

  • Closed-loop group had significantly higher PEEP and minute ventilation percentage and improved static lung compliance compared with controls.
  • Driving pressure was significantly lower and survival rate was higher in the closed-loop group.
  • Net fluid balance at 48 hours was higher with closed-loop control, without adverse interaction between automated PEEP and fluid management.

Clinical Implications

Supports feasibility of automated FiO2/PEEP titration during aggressive resuscitation after burns; motivates early-phase human feasibility/safety trials and integration of closed-loop control in ventilators.

Why It Matters

This preclinical randomized study demonstrates that closed-loop ventilatory control paired with decision-support resuscitation can improve survival in severe inhalation-injury ARDS, supporting translational efforts toward ICU automation.

Limitations

  • Preclinical animal model limits external validity to human ICU settings
  • Short observation window (48 hours) and small sample size (n=17) may overestimate effect sizes

Future Directions

Conduct human feasibility and safety trials of closed-loop FiO2/PEEP control with integrated fluid resuscitation decision support; evaluate longer-term outcomes and interaction with sedation, hemodynamics, and lung injury heterogeneity.

Study Information

Study Type
RCT
Research Domain
Treatment
Evidence Level
V - Preclinical randomized large-animal experiment; mechanistic/efficacy signal
Study Design
OTHER